-
1
Unanchored simulated treatment comparison on survival outcomes using parametric and Royston-Parmar models with application to lenvatinib plus pembrolizumab in renal cell carcinoma
Published 2025-01-01Subjects: “…Simulated treatment comparison…”
Get full text
Article